The BSE Midcap index and Smallcap indices also finished with smart gains of 1 per cent and 1.5 per cent, respectively.
ICRA expected strong performance of Gokaldas Exports in the coming quarters on the back of its established market position and strong relationship enjoyed with large international customers.
The benchmark Sensex ended the session at 57,420 - a gain of 296 points, or 0.5 per cent
After listing, the company has a market capitalisation of Rs 615.47 crore
Main stock indexes in the United States are eyeing a third straight yearly gain, with the benchmark S&P 500 on track to close out the year 26.4% higher
Domestic mutual funds (MFs) pumped in Rs 76,779 crore (about $10.2 billion) into the markets this year until December 22
Two studies showed that Omicron's hospitalisation risk is less than the Delta variant
The shares of footwear retailer Metro Brands on Wednesday listed with a discount of nearly 13 per cent from the issue price of Rs 500 and settled over 1 per cent lower
While the equity categories had a bumper year, the going was tough for debt fund managers
The market breadth was positive, with 2,239 stocks gaining against 1,095 stocks declining on the BSE
High valuations, exuberance around many new-age businesses, and the excess money floating around in the markets are a source of short-term worry
Equity MFs have emerged as a saviour in domestic markets as FPIs have continued to sell stocks
The bull run over the past year has fuelled a surge in interest in direct stock investing, especially among the millennials
Investor wealth to the tune of Rs 6.8 trillion was wiped in Monday's mayhem on the D-Street
Nifty ends below 17,000 mark, Sensex sees biggest decline since December 6
The BSE Midcap and Smallcap indices ended with losses of 2.4 per cent and 2.1 per cent, respectively. Declining stocks outpaced advancing shares in more than 2:1 ratio
The broader markets however finished in red, the breadth too was negative
Analysts say a currency depreciation creates an inflationary overhang in the economy, depressing equity valuation
The broader markets also weakened towards the end of the trading session; Sun Pharma, however, gained nearly 3 per cent.
Inflation, winding down of stimulus from major central banks such as the US Fed and the ECB, developments in China and the impact of the new Covid variants, if any, are some of the key risks